Simplifying Global Compliance
FTC: Number of Pay-for Delay Settlements Continues to Drop
The number of “pay-for-delay” patent settlements agreed to by pharmaceutical companies in fiscal 2015 declined from the year before, according to a report from the Federal Trade Commission.
To View This Article:
Subscribe To Generic Line
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing